Hunting Hill Global Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-200,000
Closed -$26M 27
2019
Q1
$26M Buy
+200,000
New +$24.3M 4.77% 9

Other funds holding LLY

Hunting Hill Global Capital's LLY Position: Q2 2019 in Review

Hunting Hill Global Capital sold out of Eli Lilly (LLY) in Q2 2019, closing a stake of 200,000 shares — an estimated $26M sold.

Hunting Hill Global Capital first reported a position in LLY in Q1 2019 and held it in 1 quarter. The position peaked at $26M in Q1 2019. 1,516 funds tracked by Wall St. Rank hold LLY as of Q2 2019.

  • Hunting Hill Global Capital reported no remaining Eli Lilly position as of Q2 2019 after selling out during the quarter.
  • Hunting Hill Global Capital sold 200,000 Eli Lilly shares in Q2 2019, an estimated $26M.
  • Hunting Hill Global Capital first reported a position in Eli Lilly in Q1 2019 and held it in 1 quarter.
  • Hunting Hill Global Capital's Eli Lilly position peaked at $26M in Q1 2019.
  • 1,516 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2019.

Based on Hunting Hill Global Capital's 13F filing for Q2 2019, filed 14 Aug 2019.